Form4insider filings, from the source

SEC Form 4 · accession 0001688199-26-000004

Dianthus Therapeutics, Inc. /DE/ · DNTH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Simon Read
Director
Period of report
Aug 10, 2026
Accepted (ET)
Aug 11, 2026 · 5:10 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001690585

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockAug 10, 2026M2,777$18.36A2,777D
Common StockF2Aug 10, 2026S70$107.11D2,707D
Common StockF3Aug 10, 2026S737$108.17D1,970D
Common StockF4Aug 10, 2026S831$108.95D1,139D
Common StockF5Aug 10, 2026S272$109.96D867D
Common StockF6Aug 10, 2026S470$111.05D397D
Common StockF7Aug 10, 2026S397$111.77D0D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F8$18.36Aug 10, 2026M2,777D—May 22, 2035Common Stock2,77722,223D

Explanation of responses